Abstract
Diclonate P (sodium diclofenac, Pliva, Zagreb) was used in the treatment of 74 patients with rheumatoid arthritis as the basic antirheumatic drug. Analgesic and antiinflammatory activity and good tolerance of three dosage forms (tablets, suppositories, ampoules) of diclonate P were established on a statistically significant basis. In some parameters the drug compares very favourably with its chemical analogs.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
-
English Abstract
MeSH terms
-
Arthritis, Rheumatoid / drug therapy*
-
Delayed-Action Preparations
-
Diclofenac / administration & dosage*
-
Diclofenac / adverse effects
-
Female
-
Humans
-
Injections, Intramuscular
-
Male
-
Middle Aged
-
Remission Induction
-
Suppositories
-
Tablets
Substances
-
Delayed-Action Preparations
-
Suppositories
-
Tablets
-
Diclofenac